Search
Phathom Pharmaceuticals Inc
PHATAdd to Watchlist
7.480USD
-0.270-3.48%
Close 09-18 16:00（ET）
598.92MMarket Cap
LossP/E TTM
After-hours 16:10 (ET)7.470USD-0.005-0.07%
After-hours 16:10 (ET)TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-3.48%
5 Days
-10.53%
1 Month
-13.02%
6 Months
-33.27%
Year to Date
-54.91%
1 Year
-33.27%
Key Figures
7.630Open
7.763High
59.60KVolume
LossP/E TTM
9.38P/E Dynamic
--Dividend TTM
0.07%Turnover Ratio
7.750Prev. Close
7.465Low
450.26KTurnover
LossP/E Static
-1.74P/B
0.00%Div Yield TTM
-52.49%ROA
18.31052wk High
0.04Volume Ratio
-334.33MNet Profit
80.07MShares
-2.0938EPS TTM
0.53Beta
-3489.00%ROE
7.46552wk Low
2.97%Amplitude
79.68%Gross Margin
598.92MMarket Cap
-2.71Reward/Risk
4.07%Risk Rate
More news coming soon, stay tuned...
Phathom Pharmaceuticals Inc's Score
0.14vs previous score
Forecast8.33
Financial Health8.20
Technical5.10
Valuation Dimensions8.78
Institutional Confidence7.00
Risk Assessment4.92
Media Coverage
Coverage Level
Very Low
Very High
Negative-
Analyst Rating
Phathom Pharmaceuticals Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.21/-0.25
Revenue / Forecast
74.27M/72.79M
Phathom Pharmaceuticals Inc Profile
SectorPharmaceuticals
Ticker SymbolPHAT
Number of employees427
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Frazier Life Sciences Management, L.P. | 15.63% |
| Medicxi Ventures (UK) LLP | 9.36% |
| Millennium Management LLC | 5.24% |
| Abingworth Management Limited | 4.38% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 22.16% |
| Venture Capital | 19.25% |
| Private Equity | 16.16% |
| Investment Advisor/Hedge Fund | 12.43% |
Related Instruments
+0.04%
-0.09%
-0.04%
-0.02%
-0.19%
-0.39%
+1.55%
-0.52%
+0.07%
+0.12%
+0.35%
-1.55%
-1.65%
-1.53%
-0.56%
-0.58%
-0.55%
-2.55%
-0.73%
-0.42%Popular Instruments
51860.200
+126.200 (+0.24%)
29803.600
+138.900 (+0.47%)
7678.700
+19.600 (+0.26%)
14455.000
+35.000 (+0.24%)
65200.000
+121.000 (+0.19%)
6260.600
+29.800 (+0.48%)
93.966
-2.035 (-2.12%)
336.130
-0.870 (-0.26%)
222.270
+2.930 (+1.34%)
4361.890
-15.440 (-0.35%)
FAQs
What is the current price of Phathom Pharmaceuticals Inc (PHAT)?
The current price of Phathom Pharmaceuticals Inc (PHAT) is 7.48.
What is the symbol of Phathom Pharmaceuticals Inc?
The ticker symbol of Phathom Pharmaceuticals Inc is PHAT.
What is the 52-week high of Phathom Pharmaceuticals Inc?
The 52-week high of Phathom Pharmaceuticals Inc is 18.31.
What is the 52-week low of Phathom Pharmaceuticals Inc?
The 52-week low of Phathom Pharmaceuticals Inc is 7.46.
What is the market capitalization of Phathom Pharmaceuticals Inc?
The market capitalization of Phathom Pharmaceuticals Inc is 598.92M.
Is Phathom Pharmaceuticals Inc (PHAT) currently rated as Buy, Hold, or Sell?
According to analysts, Phathom Pharmaceuticals Inc (PHAT) has an overall rating of Buy, with a price target of 20.50.
What is the Earnings Per Share (EPS TTM) of Phathom Pharmaceuticals Inc (PHAT)?
The Earnings Per Share (EPS TTM) of Phathom Pharmaceuticals Inc (PHAT) is -2.09.